Sign in to view content

Safety of Intravitreal Pegcetacoplan in Geographic Atrophy: Results from the Phase 3 DERBY and OAKS Trials

David S. Boyer, MD

Video
Published 2021

Related

Quantitative Contrast Sensitivity Longitudinal Changes Correlate Better Than Visual Acuity With Geographic Atrophy Progression
John B. Miller, MD
Annual Meeting Talks
2024
Charlson Comorbidity Index As a Predictive Tool in Patients With Exudative Age-Related Macular Degeneration in Delay of Care
Vivienne S. Hau, MD, PhD
Annual Meeting Talks
2024
Treatment of Geographic Atrophy Secondary to AMD With Pegcetacoplan: Two-Year Outcomes From the Randomized Phase 3 DERBY and OAKS Trials
Charles C Wykoff, MD, PhD, FASRS
Updates from the Field
2022

Category: AMD-Non-Neovascular

See more